Polymorphism in the 3′-untranslated region of the thymidylate synthase gene and sensitivity of stomach cancer to fluoropyrimidine-based chemotherapy
Authors:
- 20 January 2006
- journal article
- Published by Springer Nature in Journal of Human Genetics
- Vol. 51 (3) , 155-160
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Polymorphisms of thymidylate synthase in the 5′- and 3′-untranslated regions associated with risk of gastric cancer in South China: a case–control analysisCarcinogenesis, 2005
- Thymidylate synthase gene promoter polymorphisms are associated with TSmRNA expressions but not with microsatellite instability in colorectal cancer.2005
- Thymidylate Synthase Gene Polymorphism Predicts Toxicity in Colorectal Cancer Patients Receiving 5-Fluorouracil-based ChemotherapyClinical Cancer Research, 2004
- Polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase genes and the susceptibility to esophageal and stomach cancer with smoking.2004
- A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levelsPharmacogenetics, 2004
- Gastric cancer treatment: a systematic review.Oncology Reports, 2004
- Ethnic Variation in the Thymidylate Synthase Enhancer Region Polymorphism among Caucasian and Asian PopulationsGenomics, 1999
- Functional Analysis and DNA Polymorphism of the Tandemly Repeated Sequences in the 5'-terminal Regulatory Region of the Human Gene for Thymidylate Synthase.Cell Structure and Function, 1995
- Gastric Cancer: Strategies in the surgical treatment of gastric carcinomaAnnals of Oncology, 1994
- Chemotherapy of carcinoma of the stomachCancer Treatment Reviews, 1993